Idea Description
Supplementary Information
Detailed Submission Data
Innovation 'Elevator Pitch':
ConCERT-D is an integrated clinical & research solution designed with Dementia leading clinical experts specifically for the treatment, identification & management of dementia patients, providing results and medication management. 
Overview of Innovation:
ConCERT-D displays captured mental assessment scores for tests including the Mini Mental State Examination (MMSE) in a graphical way enabling Clinicians to relate fluctuations in scores with events that would have happened in the meantime

The medication module allows Clinicians to keep track of the patient diagnosis, prescribed drugs, related side effects, allergies and other conditions. The in-built drug formulary is specially geared towards dementia patients. The accumulative anticholinergic cognitive burden (ACB) is automatically calculated allowing Clinicians to take better decisions, ultimately reducing the risks of cognitive impairment & death

The medication module enables Clinicians to check the dosages for antidepressants and anti-psychotics being taken by the patient as a percentage of the maximum dosage set for these medications

A Research Register for Clinicians to inform Clinical practice
The ability to easily identify patients and carers that match a clinical trial’s participation criteria provides a highly effective tool to increase participation in research. Researchers can build the appropriate participation criteria for clinical trials in ConCERT-D. The system can automatically report on patients that are eligible for participation in studies

Once a patient is identified the clinical researchers speaks to their carers for advice. In some cases internal background checks, tests and screening are carried out. If a patient is found to be suitable and willing to take part he/she is enrolled onto the clinical trial. On the other hand if found unsuitable the reason why is logged and the patient is automatically excluded from subsequent participant searches for that trial

ConCERT-D facilitates accreditation in programs including as The Memory Services National Accreditation Program (MSNAP) allowing hospitals to benchmark their services against national standards and provide quality assurances. MSNAP also enables staff to ensure they are making a meaningful difference to people’s lives as well as supporting implementation of national clinical excellence guidelines. ConCERT-D supports Clinicians to capture MSNAP information during interactions with the patient & then generate reports with the information gathered

These reports allow the identification of trends, assessment of completeness & are of great use for assessors when rewarding accreditation. This functionality can be adapted to other similar accreditation programs
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
Similar Content4
Innovation 'Elevator Pitch':
Yecco is a fully digital telehealth & telecare self-management platform for monitoring all aspects of a person’s past & real-time health status. Our products also allow environmental monitoring & home automation to enable full remote care & support.
Overview of Innovation:
Yecco brings new & exciting ways of data sharing as the trend moves towards patients managing their health & taking control of their health data.

Our solutions facilitate self-management of chronic conditions & can help to reduce emergency readmissions to hospital. In 2012-13 more than 1 million emergency readmissions within 30 days of discharge cost an estimated £2.4 billion.* Yecco can be used to support hospital discharge as it monitors the safety & health of a person living when back in their own home. 

View our video & see how Yecco can support a patient with Diabetes & COPD –

Yecco’s own private, social network allows its patients, health & care professionals to share medical & device information with any connection they wish, enabling consumers, health & care professionals to share real-time medical & device data. It can be used at home, work, care settings, medical & care facilities.

Features include:
  • Share medical data with chosen family, friends & clinicians
  • Ability for another person to manage your profile
  • Create & send group messages & on your timeline
  • Keep a check on your health in real time using the Yecco medical devices or add readings manually
  • Add thresholds to alert chosen connections 
  • Store personal, medical & medication information
  • Built in calendar & reminder support
  • Video to stay in contact/facilitate remote consultations
  • Message facility
  • Task planner
  • Group connection
  • Educational content
  • Response questionnaires    
Yecco medical devices can measure vital signs with accuracy & precision using Bluetooth to automatically connect to an iOS or Android device(s) using the Yecco App for a simple & effortless measurement in real time.

The Yecco multi-function sensor offers power & flexibility that’s not been available before in a home sensor. Paired with the Yecco App & through the use of the Yecco Docking Station it can automatically detect abnormalities in physiological data, alerting chosen connections on the Yecco network.
The multi-function sensor can connect directly to the WIFI network. Features include the ability to activate the camera on the mobile device to investigate alerts.

  • Motion detection
  • Door & window open or closed status
  • Smoke detection
  • Carbon monoxide detection
  • Temperature & humidity
  • Add separately & plug in:
    • Bed occupancy sensing pad
    • Enuresis pad (to detect for moisture in a bed or chair)
    • Rechargeable battery
There is the option to keep a check on your health using the Yecco Wearable Watch.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Digital health
Benefit to NHS:
Rising demand for services, combined with restricted or reduced funding, is putting pressure on the capacity of local health and social care systems.
The NHS spends around £820 million a year treating older patients who no longer need to be there.
Yecco Pro App
Yecco Pro is a licensed cloud-based interface that enables organisations to remotely monitor multiple patients.
Yecco Pro gives medical professionals multi patient monitoring with real time data for early intervention. Powerful threshold and notification options assist all professionals to give improved patient outcomes and increased safety.

Features include:
  • Receives real time data for early intervention
  • Interface for clinician to patient communication
  • Set thresholds to assist in disease management and early intervention for improved patient outcomes and safety
  • Set alerts / notifications
  • Group patients
  • Filter and create reports (CSV)
  • Video conference calling
This modular platform enables Yecco to add other 3rd party modules or interface to Electronic Patient Record system or data contextualisation platforms that enable intelligent triage and diagnosis across a range of data sources

Yecco's product are currently being used by Surrey and Boarder Partnership testbed that is monitoring the health and wellbeing of patients that have mild o moderate levels of dementia. The aim of the project is to assist clients in monitoring and reduce the burden on front line NHS services. (GP’s appointments, health work home visit and hospital re-admissions). The health and wellbeing reading take form the Yecco devices is being monitor in partnership with the KSSAHSN/University of Surrey. Currently awaiting health economics stats and data from project.
Online Discussion Rating
4.00 (2 ratings)
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
The past few decades have seen significant improvements in life expectancy, however, rising longevity brings increasingly complex & chronic health conditions, placing substantial demands on health & social care services.
At the same time services are experiencing significant financial pressure & need to find ways of lowering costs while maintaining or improving the quality of care provided.
This requires new ways of working in order to meet increasing demand & deliver care that is safe & cost‑effective while reducing reliance on hospital & institutional based care.
Technology can help to support these new ways of working.
When hospital discharge goes wrong it comes at significant cost both to individuals & to the health and social care system. In 2012-13 there were more than 1 million emergency readmissions within 30 days of discharge costing an estimated £2.4 billion. Source:

The number of older people in England is increasing rapidly, by 20% between 2004 & 2014 & with a projected increase of 20% over the decade to 2024. Hospitals have also experienced increases in the number of emergency admissions of older patients, by 18% between 2010-11 & 2014-15. Older patients now account for 62% of total bed days spent in hospital.
The relative growth in numbers of older people is important. The number of older people with an emergency admission to hospital increased by 18% between 2010-2011 & 2014-15 (compared with a 12% increase overall).
While NHS spending has grown by 5% in real terms between 2010--11 & 2014-15, local authority spending on adult social care has reduced by 10% in real terms since 2009-10.  Source:
Yecco is an innovative solution that monitors the safety & health of a person living in their own home or in a care setting.  This combined telehealth & telecare solution can enable health & care providers to meet the health & social care needs of individuals in their charge.
By using Yecco technology to monitor if a person is physically safe, for example that they have not left the cooker on or had a fall, as well as critical indicators such as blood pressure or blood oxygen levels to indicate that they are not medically at risk can improve user’s quality of life & reduce long-term health care costs.

Yecco can help to keep people safe in their own home & reduce the number of unnecessary hospital visits, increase confidence in users to manage their own health & alleviate the pressures & concerns of caregivers.
Current and planned activity: 
We wish to work with regional health & care providers & WMAHSN's Patient Safety Collaborative & Care Home Network. We also wish to explore if our technology can be used to support Mental Health Services, possibly to monitor & support patients coming off medication.
Our products are being used by Surrey & Boarder Partnership testbed to monitor the health & wellbeing of patients with mild to moderate levels of dementia. The project's aim is to assist clients in monitoring & reduce the burden on front line NHS services (GP appts, health work home visit & hospital re-admission). The health & wellbeing readings taken from Yecco devices is being monitored in partnership with KSSAHSN/University of Surrey.
We previously demonstrated our products & services to EMAHSN & are currently involved in the Falls Prevention tender (EMAHSN led). Yecco products & services have been purchased by Neath & Port Talbot Borough Council to monitor & support regional LD clients (awaiting deployment date).       
What is the intellectual property status of your innovation?:
Yecco has developed its software and applications and retains the IP to this. It also owns IP in some of the hardware products developed in-house (sensors and IoT gateways). Some 3rd party integrated products (such as generic medical devices for vital sign monitoring are not Yecco IP). These products are in the process of being further protected. 

Yecco is currently in use in the NHS England IoT testbed with Surrey and also within other local authorities. Our products comply with the required data model, structure, coding and security requirements that have been dictated. We are also working with established telecare and telehealth organisations where compliance is required / requested to various standards and integration with 3rd party alarm management systems.
Return on Investment (£ Value): 
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Yecco are currently involved in Surrey and boarder partnership NHS foundation trust testbed programme for monitoring patients with mild to moderate dementia. The project is currently ongoing. yecco have requested information relating to the impatch of the project and health economic details. As soon as this information has been published yecco willl add this information into the meridian system 

Read more
Hide details
Innovation 'Elevator Pitch':
The Silhouette® solution enables integrated care ,closer to home, for patients with diabetic foot ulcers, using digital wound imaging and objective wound healing data available remotely in real time, to improve patient care and reduce system costs.
Overview of Innovation:
Digital Silhouette® solution for diabetes foot management improves clinical objectivity and patient experience 
Diabetes is a major health challenge in the UK with a rapidly increasing number of people affected. Active disease of the foot is a crisis situation for a patient with diabetes and requires timely referral and management. A proven solution for reliable and remote monitoring of diabetes foot ulcers, Silhouette, is available to support integrated care, releasing capacity in acute out-patient clinics and supporting safe care in community settings. 

An EMAHSN-supported demonstrator established with Derby Teaching Hospitals NHS Foundation Trust and Derbyshire Community Healthcare Services Trust has led to improvements in clinical management and patient experience:

Clinical Lead, Professor Fran Game, Consultant Diabetologist, Clinical Director R&D, Derby Teaching Hospitals NHS Foundation Trust:
“As a result of implementing the Silhouette system, we have been able to safely transfer an increasing portion of patients for treatment in community clinics and have improved waiting times in our out-patient clinic. Importantly, patients are happy with the new model of care. In a survey following introduction of digital ulcer assessment, 71% of patients reported a greater confidence in the care they had received.”
Service User, Patient Experience:
Patient A.S. from Kilburn said; “We only live just down the road from the clinic and it saves so much time for us, it is much closer to home than the hospital is, which means we are not spending so much time getting to and from appointments.”

Innovation Solution Deployed:
  • Silhouette® digital wound imaging & information system deployed as a telehealth solution, to build community capability for on-going treatment.
  • 3D measurement technology accurately maps ulcer size, enabling clinicians to assess wound progress & response to treatment with objective data
  • Enables reliable & remote monitoring of patients with active DFU & chronic complex wounds
Impacts to date:
  • EMAHSN independent qualitative and quantitative evaluation
    –Over-whelming improvement in patient experience
    –Positive feedback from clinicians
    –Reduction in acute Out-Patient over-crowding
    First year 462 (7.4%) appointments moved to community
    First year 5 camera, total investment £66k, first year savings £35k
    Business case based upon reduction in treatment/tariff costs

SilhouetteStar Camera

Dr Bruce Davey - CEO ARANZ Medical with SilhouetteStar Camera


Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
The Silhouette digital solution for diabetes foot management has been successfully deployed in an EMAHSN-supported Demonstrator. The deployment of Silhouette is enabling an integrated diabetes foot pathway in Southern Derbyshire , linking care across acute and community.
A Business Case is available on request from EMAHSN, please email 
The reported benefits to date include:
Patient outcomes: Greater convenience for patients, through treatment in community, less time waiting, less travel, with remote oversight by specialists to provide joined up care
Efficiency gains: health care professionals can access the secure Silhouette digital data quickly and in real time allowing escalation and de-escalation from community to hospital based on objective clinical data on ulcer status and risk. Adminstration reduced with automated reporting of patient's ulcer treatment and progress to GPs, reducing admin time and cost of letters to GPs.
Cost-effectiveness: A shift of hospital treatment appointments to community, trending at 8% has yielded savings on tariff costs across whole system. Cost reduction on adminstration involved with reporting to GPs.  
Online Discussion Rating
5.00 (1 ratings)
Initial Review Rating
4.80 (2 ratings)
Benefit to WM population:
Health: Using objective clinical data on ulcer healing to building efficiency in acute out-patients, building community capability for care closer to home to support improvements in patient safety, experience and outcomes.
Wealth: Better use of NHS funds to enable staff to manage patients with a focus on outcomes rather than activity 
Growth of a UK SME to create jobs and new solutions for the NHS.
Current and planned activity: 
Current activity: 
Entec Health and ARANZ Medical are actively engaging with expansion of Silhouette deployment across Derbyshire county as part of the Derbyshire NHSE Diabetes Transformation programme. In addition, a number of other NHS Diabetes Foot Services are working with us to develop and deploy a Silhoeutte-enabled MDFT in Nottinghamshire and Cambridgeshire & Peterborough. These initiatives involve CCG /STP stakeholders to support sustainability plans for the innovation and transformation work for long-term gain for patients and the NHS.
Planned activity
We are seeking to work with CCGs/STPs and NHS Providers who have a vision for deploying Silhouette in diabetes foot ulcer management and chronic wound management to drive forward a patient-centred, outcomes-led, service. 
What is the intellectual property status of your innovation?:
Silhouette digital wound assessment and information management system is developed and manufactured by ARANZ Medical Limited, based in New Zealand, with ARANZ Medical Limited having ownership of IP for Silhouette brand and Silhouette technology.

Return on Investment (£ Value): 
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Read more
Hide details
Innovation 'Elevator Pitch':
The bespoke training programme aims to increase mental health awareness and increase skills in identifying and managing mental health crisis with emphases to referral pathways that can be applied in operational practice by frontline professionals.
Overview of Innovation:
Rapid, Assessment, Interface and Discharge Plus takes a more localised training approach and has identified priority front line services that frequently coming into contact with those suffering from mental illness and potentially at risk of crisis i.e. Police officers and Community healthcare professionals who are working with individuals with both physical and mental health difficulties.

The training aims to increase knowledge and understanding of mental illnesses as well as support early referral and appropriate management of individuals who are experiencing deterioration in their mental health. The overall aim is to build confidence and competence in front line professionals and generate a supportive and informed approach when working with those in mental health distress.

The training modules are as follows:
  • Understanding mental illness: Signs and Symptoms of mental health
  • Effective de-escalation and communication skills
  • Understanding Mental Health Act (1983) and Mental Capacity Act (2005)
  • Crisis Prevention and Management (including risk assessment of suicide and self-harm)
  • Dementia
The training package offers provision to tailor elements of the content to suit the locality’s policy and services available, should organisations wish to implement the  training. For example, the 'Crisis Prevention and Management' module explores referral pathways and services available within Birmingham and Solihull Mental Health Trust. These could be easily amended to reflect the organisations services to ensure the training maintains its bespoke, localised approach. The training can be customised but would generally take a full day to cover all modules.

This allows for local frontline professionals that come in contact with mental health patients to be able to identify and prevent patients going into crisis by referring patients to access appropriate mental health support in a timely manner.

The training is delivered by a registered mental health professional to ensure that the full potential of learning amongst participants is achieved. The experience and understanding of such an individual will aid questions posed throughout the training and allows them to draw to from previous experiences/scenarios from real life mental health practice within the delivery.
Stage of Development:
Close to market - Prototype near completion and final form may require additional validation/evaluation and all CE marking and regulatory requirements are in place
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Education, training and future workforce / Innovation and adoption
Benefit to NHS:
National directives indicate that, in general, the public should have a baseline knowledge and understanding of mental illness (Public Health England, NHS Five Year Forward View). It is nationally acknowledged that many patients with long term physical health care conditions have a diagnosed mental health issue (NHSE FYFV). Due to limited training and data sharing the co-ordination of care for these patients is often fragmented (Crisis Concordat, 2015). This may result in patients experiencing mental health crisis and entering the urgent care pathway unexpectedly. This causes pressure on urgent care services and could also impact the patient experience.

Our vision is to help develop a community healthcare workforce that is fully trained in mental health, with access to the right tools and pathways to support patients suffering with mental health issues. This will ensure that patients with comorbid conditions are positively supported to access the right care, at the right time in the right place. The better management of the mental health care can have a positive impact to patients' care as well as possibly avoiding their mental health deteriorating further.

In 2015 the Mental Health Network Confederation highlighted; "the police and mental health providers need to understand each other’s legal powers, roles and responsibilities "to manage /reduce the risks associated with mental health crisis". Additionally, the police often come in contact with people experiencing mental health distress and usually have to manage difficult and complex situations. Training is needed to equip them to recognise and assist when someone has a mental health issue or learning/intellectual disability. This is in line with the College of Policing requirements for mental health awareness training within the police force.

The police are frequently in contact with people suffering from mental health problems, so to be able to identify these symptoms and be able to direct them to right pathway in a timely manner is a huge benefit as it can save the person further unnecessary complications and faster access to help. The police would also benefit by being able to correctly manage people undergoing mental health distress when responding to mental health-related incidents. They will be able to acquire practical skills to spot the triggers and signs of mental health issues and be able to confidently step in, reassure and support a person in distress.
Initial Review Rating
1.00 (1 ratings)
Benefit to WM population:
Within the West Midlands 20-40% of police time is dedicated to those experiencing mental health difficulties. Therefore, the ability to identify symptoms and signs of mental health distress and be able to refer patients to the appropriate pathways ensures a better and efficient system. The training helps police develop skills to manage those with mental health illness/facing mental health crisis and saves time and resources. The training will cover the Mental Health Legislation and Mental Capacity Act which aligns with the College of Policing training requirement for the West Midlands Police.

By training the Birmingham Community Healthcare Trust staff, this supports staff being able to ensure the patients with long terms conditions that have signs of mental health issues are supported to access the right care in a timely manner. Having an understanding of the mental health support pathways and services for patients avoids patients experiencing mental health crisis by early intervention and reduces unplanned emergency visits to the urgent care system.

There is wider scope however for target audiences and suggestions to be considered for future delivery of the training include:
  • Wider community and health care teams within Birmingham/ Solihull
  • Schools, universities and colleges
  • Ambulance services
  • Fire Services
  • Workplace learning and team building
Current and planned activity: 
To date, the RAIDPlus training package has been created and delivered by the mental health trainer who is a registered mental health nurse with a number of years’ experience within acute mental health. The training was delivered to 1600 staff across the West Midlands Police and 150 Birmingham Community Healthcare staff.  

The police training was tailored and aligned to the learning objectives of West Midlands Police. This is in connection to the College of Policing requirements and Authorised Professional Practice for mental health within the police force. The community trust training was tailored to meet the learning needs of staff to capture the referral pathways and crisis prevention elements relevant to their services. Overall, the training was positively received by staff and early outcomes suggest improved capacity to provide supporting interventions to reduce the risk of crisis.
What is the intellectual property status of your innovation?:
BSMHFT is the provider of this training package.
Return on Investment (£ Value): 
Return on Investment (Timescale): 
Ease of scalability: 
Read more
Hide details
Innovation 'Elevator Pitch':
Life Echo is a therapeutic personal phonic map of patients positive memories to reconfirm and generate memory management and interaction and how they can approach death.
Overview of Innovation:
Wiggan has discovered the possibilities that phonic recordings offer social care and Life Echo could offer alternatives within therapy and the skills of hearing that can address deep emotional and mental struggles.
Life Echo will address some of the issues relating to dementia and bereavement. (Primarily in first stages, then into other areas) and that Life Echo will explore the impact of sound on mental and emotional wellbeing. 

Previous activity has been building the project on the notion that hearing is one of the last senses to leave when a patient is terminally ill, this could possibly change how people interact with their own memories and how they can approach death.
This first stage of the project had shown it has great potential to become part of the service provision in end of life care and could be rolled out beyond the local area to become citywide and possible a regional or national project.
Positive memory trigger points with individuals receiving end of life and palliative care at the John Taylor Hospice in Birmingham and early sufferers of dementia to create ‘Life Echoes’ or personal phonic maps create this work.
The process encourages patients to reconfirm or establish memory routes, generating deeper, more intensive memory emersion through sound recall.
Life Echo is the sound of patients positive memories, as they consider an age or time period that has a positive significance for them, for each person this will be different and unique.
The Life Echo is an experience, alone or with family/ carer/staff. It is not a sound track of sound effects, but an abstract, therapeutic sound narrative based on the data shared by the patient.
This programme impacts upon end of life care and enhances the possibilities of ‘dying well’, it leaves a tool for the participant, a legacy for the family and potentially offers a process to delay the early on set of dementia.
Life Echo has the potential to become part of the service provision in end of life and dementia care. 

Life Echo is at inception/ R&D phase, so measurement guidelines are not yet fully formed. Anecdotal evidence, through film recordings and written documentation suggests that participants are extremely positive towards their experience however, this positivity needs to be formalised in order to establish clear frameworks for assessing success. 

The next step is to evaluate the impact of Life Echo on user, carer and family and develop a digital self perscription version
Stage of Development:
Evaluation stage - Representative model or prototype system developed and can be effectively evaluated
WMAHSN priorities and themes addressed: 
Mental Health: recovery, crisis and prevention / Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:
 Our proof of concepts studies plus the 18 months of ongoing implementation of Life-Echo in the setting of our base West Midlands hospice have given us very considerable confidence to describe the followings features among those patients in whom increasing memory deficit is an pressing and relentlessly increasing daily problem.
  1. Promotes welfare benefit
[Increased and noted positive mood up-lift for the patient and more general care & welfare benefits]
  • For the patient : elevation of affect, pleasure and increased tranquility
  • For the carers : additional benefit and assistance to those directly managing their daily care, and more generally in improved mental accessibility of the patient towards close relatives and carers sharing their daily life
  1. Delivers financial benefit
  • Essentially in terms of increased quality time salvaged (due to the patient’s lighter affect and increased communicability) 
  • Reduced difficult times of wearisome management  (due to mental inaccessibility of the patient)
  1. Motivates the seeking out of further application areas and business
  • The Life-Echo business, small as it is, has over the last four years been approached by some twenty different potential users of the equipment and ideas in a truly impressive range of situations – schools, adult education, mental health therapy, relaxation for stressed children and adults in hospitals, prisons, detention centers as well as for well and healthy individuals in challenging and extreme circumstances.
For one reason of another [possibly because the technology is eminently affordable and flexible in design and because the fundamental idea of access to personal memory and imagination is so alluring] Life-Echo is overflowing this development possibilities. For those purchasing Life-Echo it is so easy to use in opening up new application areas. Indeed in situations like hospices and hospitals for these possible developments can readily be viewed as revenue generating.
Online Discussion Rating
5.00 (1 ratings)
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
Presently our experience is in the palliative day-care setting, where even if this were to be the only application are, we would base the computation on exactly the three areas shown in detail above; and moreover these would need to be delivered by a system which costs in a Life-Echoist  at each of the three stages – mapping, creation, reproduction.
[Nevertheless, our present direction of technical development is for Life-Echo to be both self-derived and self-administered – which opens up the option for creation to be Life-Echoist –supported or even self-created.]
Simply applying to Life-Echo the epidemiology of dementia in the over 60’s population of West Midlands

and on the basis of the benefits described at A, above:
            Promotes welfare benefit :
  • Over 1.5 million people in the UK (West Midlands at 8.85% = 130,000) therefore, including both people with dementia and their carers, would potentially benefit from dementia treatments today.
Delivers financial benefit :
  • Per patient day using Life-Echo we estimate a conservative net financial benefit of £10.
Motivates the seeking out of further application areas and business: 
  • Per institution adopting Life-Echo per year we estimate a conservative ‘novel usage’ return to them of between  £2k and 20k per year.
If Life-Echo looked to monetarizing for its own return just 15% of this potential customer gain then for every 80-users that would be 15% of £((80*365*10) + (3*5,000)) = £46,000
[based on present situation of 80 users in 3 centres for a single year.]
This is the present base level (£46k p.a. 2016) – and we expect to increase this 10 fold in 1 year (£460k p.a. 2017) and 100 fold in the following 4 years (£4.6m p.a. 2021)
Current and planned activity: 
Life Echo is  being considered with the Q.E wellbeing team for the YPU Cancer Ward and Dementia Ward , who have seen the postive impact and change it can bring to patient and carer / staff prioritsed costings have limited thier engagment at this point . Anthony Cobley was championing the project to be at the Q.E. John Taylor hospice are a keen stakeholder as the porject started there and they are eager to see it develop. There are also other organisations waitng to run in part ir full programme . These are St.Andrew's Forensic , T.E.A Project in Sri Lanka , Cotteridge School, Newton Dee in Scotland ,SIFA, Ty Hafan ,CRISIS Birmigham and HMP Brimingham. (see supporting document for more details ). In terms of development support there is interest in its software translation potential from Microsoft and EnablediD. If successfull with this funding to develop a digital memory atlas and / or evaluation on patient / carer diginty , then these partners will be secured for next phase. 
What is the intellectual property status of your innovation?:
Life Echo as a name and logo is trademarked , however the copyright and patenting of IP , process etc are not yet completed but in progress right now. ( This is where guidance and support is requred .) I realise the extreme importance of this and do need to get that done , however this needs a £3000.00 injection now to get this status complete.
Return on Investment (£ Value): 
Return on Investment (Timescale): 
2 years
Ease of scalability: 
Regional Scalability:
West Midlands Region

1. Via our four Life-Echoist Training Courses planned for 2018 at three different palliative care locations and University Venue: 
  • John Taylor Hospice
  • Myton Hospice, Leamington Spa
  • Compton Hospice, Wolverhampton
  • BCU, Well Being and Digital Health
Each will train eight Life-Echoists:

2.  Via the 2018 Life Echo Conference – December, 2018
3.  Via the excellent offices of WMAHSN
Other Parts of the UK

We are currently working in Wales with both Children’s Hospices:

Tŷ Gobaith, Conwy
Tŷ Hafan, Cardiff

With further discussion:

2 known areas of personal impact (preliminary medical & social history/psychological/physiological)
1. Patient’s short & long form: Enhancing function, promoting relationships & social participation & finding ways for those with dementia to enjoy life are the keys to successful occupational therapy intervention. Providing education for family, care providers & clients (as they are able to understand) & promoting the persons strengths will ensure that those with dementia & their care providers have the support needed to live life to its fullest

2. Carers/Staff: The medical & clinical background to these choices is explained more fully in our Measurement Notes for the LE-Corpus
This application is about Life-Echo as a health care intervention, particularly the patient with early dementia symptoms at home or in a residential/palliative care environment, along with carer(s) & medical professionals. Everything that follows here will therefore be directed to the needs & benefits of those 3 groups. However it is important to have in mind that Life-Echo already has authentication in its use from a range of other fields where its users & critics have made us aware of the depth of its effects & the impact it has had on them
Life-Echo moves the individual & motivates their behaviour & that is the common denominator of all that we have in growing corpus of our evidence. That corpus is held in a customised SQL database designed for linguistic analysis to extract sentiments & feelings across a psychological & physiological theoretical domain. Data is very carefully & painstakingly collected according to the framework (outlined in attached ‘Measures’ document). Moreover this is done in a way that as far as possible means that no recorded encounter with Life-Echo goes untapped for new or confirmatory insights into its workings
Full information on the measures to be used to gauge the success of Life Echo & how these assessments will be made are in the attached ‘Measures’ document
Adoption target:
Rejection Reason:
Needed to focus on one application.
Read more
Hide details

Created by

Share and Follow